Claris Life sciences has informed that the board of directors of the company at its meeting held on February 29, 2012, has approved the recommended dividend of Rs. 2 per equity share of Rs. 10 each, subject to the approval of the shareholders.
The above information is part of company’s filing submitted to the BSE.